These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35080939)
1. Popularity of Delta-8 THC on the Internet Across US States, 2021. Livingston MD; Walker A; Cannell MB; Rossheim ME Am J Public Health; 2022 Feb; 112(2):296-299. PubMed ID: 35080939 [No Abstract] [Full Text] [Related]
2. Public interest in ∆ Leas EC; Nobles AL; Shi Y; Hendrickson E Int J Drug Policy; 2022 Mar; 101():103557. PubMed ID: 34952279 [TBL] [Abstract][Full Text] [Related]
3. Patterns of delta 8 THC and cannabis uptake in Nebraska: A cannabis prohibition state. Humeniuk R; Habecker P; Cooper-Ohm S; Bevins RA Int J Drug Policy; 2024 May; 127():104400. PubMed ID: 38554564 [TBL] [Abstract][Full Text] [Related]
5. Delta-8 Tetrahydrocannabinol Exposures Reported to US Poison Centers: Variations Among US States and Regions and Associations with Public Policy. Smith GA; Burgess A; Badeti J; Rine NI; Gaw CE; Middelberg LK; Spiller HA; Hays HL J Med Toxicol; 2024 Oct; 20(4):389-400. PubMed ID: 39168936 [TBL] [Abstract][Full Text] [Related]
6. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC. Lile JA; Kelly TH; Hays LR Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600 [TBL] [Abstract][Full Text] [Related]
7. Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review. Poyatos L; Pérez-Acevedo AP; Papaseit E; Pérez-Mañá C; Martin S; Hladun O; Siles A; Torrens M; Busardo FP; Farré M Medicina (Kaunas); 2020 Jun; 56(6):. PubMed ID: 32585912 [TBL] [Abstract][Full Text] [Related]
8. Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis. Smith BP; Hoots B; DePadilla L; Roehler DR; Holland KM; Bowen DA; Sumner SA J Med Internet Res; 2023 Dec; 25():e49469. PubMed ID: 38127427 [TBL] [Abstract][Full Text] [Related]
9. Delta-8 THC use in US adults: Sociodemographic characteristics and correlates. Livne O; Budney A; Borodovsky J; Walsh C; Shmulewitz D; Fink DS; Struble CA; Habib M; Aharonovich E; Hasin DS Addict Behav; 2022 Oct; 133():107374. PubMed ID: 35644057 [TBL] [Abstract][Full Text] [Related]
10. Motor vehicle crash fatalaties and undercompensated care associated with legalization of marijuana. Steinemann S; Galanis D; Nguyen T; Biffl W J Trauma Acute Care Surg; 2018 Sep; 85(3):566-571. PubMed ID: 29787529 [TBL] [Abstract][Full Text] [Related]
11. Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients. Dobbins M; Rakkar M; Cunnane K; Pennypacker SD; Wagoner KG; Reboussin BA; Romero-Sandoval EA Front Public Health; 2022; 10():893009. PubMed ID: 35784239 [TBL] [Abstract][Full Text] [Related]
13. Determination of the relative percentage distribution of THCA and Δ(9)-THC in herbal cannabis seized in Austria - Impact of different storage temperatures on stability. Taschwer M; Schmid MG Forensic Sci Int; 2015 Sep; 254():167-71. PubMed ID: 26247127 [TBL] [Abstract][Full Text] [Related]
14. Impact of cannabis-infused edibles on public safety and regulation. Peralt A; Ke P; Castaneto MS J Forensic Sci; 2022 Nov; 67(6):2387-2393. PubMed ID: 36097671 [TBL] [Abstract][Full Text] [Related]
15. Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot. Pennypacker SD; Cunnane K; Cash MC; Romero-Sandoval EA Front Pharmacol; 2022; 13():921493. PubMed ID: 35734402 [No Abstract] [Full Text] [Related]
16. Impact of early-life lead exposure on adult delta-9-tetrahydrocannabinol sensitivity in male and female C57BL6/J mice. Garcy D; Boehm SL Neurotoxicol Teratol; 2023; 100():107290. PubMed ID: 37690674 [TBL] [Abstract][Full Text] [Related]
17. Serum and Urine Quantification of Delta-8 and Delta-9 Tetrahydrocannabinol Carboxylic Acid Using Gas Chromatography-Mass Spectrometry. Shell S; Clinton Frazee C; Garg U Methods Mol Biol; 2024; 2737():153-159. PubMed ID: 38036819 [TBL] [Abstract][Full Text] [Related]
18. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum. Bonnet U; Specka M; Stratmann U; Ochwadt R; Scherbaum N Drug Alcohol Depend; 2014 Oct; 143():189-97. PubMed ID: 25127704 [TBL] [Abstract][Full Text] [Related]
19. Dark Classics in Chemical Neuroscience: Δ Banister SD; Arnold JC; Connor M; Glass M; McGregor IS ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342 [TBL] [Abstract][Full Text] [Related]
20. Mapping cannabis potency in medical and recreational programs in the United States. Cash MC; Cunnane K; Fan C; Romero-Sandoval EA PLoS One; 2020; 15(3):e0230167. PubMed ID: 32214334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]